Effects of Qili Qiangxin granules in combination with Entresto on quantitative parameters of myocardial motion in patients with cardiomyopathy in end-stage renal disease
Abstract Background Cardiomyopathy is a devastating complication of end-stage renal disease (ESRD), characterized by complex remodeling and high cardiovascular mortality. While sacubitril/valsartan (Sac/Val) and Qili Qiangxin (QLQX) granules have shown individual benefits in heart failure, their com...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2026-05-01
|
| coleção: | BMC Cardiovascular Disorders |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12872-026-05791-z |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
